Details for New Drug Application (NDA): 090170
✉ Email this page to a colleague
The generic ingredient in LAMOTRIGINE is lamotrigine. There are thirty-two drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lamotrigine profile page.
Summary for 090170
Tradename: | LAMOTRIGINE |
Applicant: | Unichem Labs Ltd |
Ingredient: | lamotrigine |
Patents: | 0 |
Pharmacology for NDA: 090170
Mechanism of Action | Dihydrofolate Reductase Inhibitors Organic Cation Transporter 2 Inhibitors |
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 090170
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LAMOTRIGINE | lamotrigine | TABLET;ORAL | 090170 | ANDA | Unichem Pharmaceuticals (USA), Inc. | 29300-111 | 29300-111-01 | 100 TABLET in 1 BOTTLE, PLASTIC (29300-111-01) |
LAMOTRIGINE | lamotrigine | TABLET;ORAL | 090170 | ANDA | Unichem Pharmaceuticals (USA), Inc. | 29300-111 | 29300-111-05 | 500 TABLET in 1 BOTTLE, PLASTIC (29300-111-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Oct 6, 2011 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | Oct 6, 2011 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 150MG | ||||
Approval Date: | Oct 6, 2011 | TE: | AB | RLD: | No |
Complete Access Available with Subscription